Source: Annual Congress 2009 - Airway inflammation and asthma control
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Saito, Y. Sato, T. Nikaido, Y. Inokoshi, K. Saito, N. Nakagawa, A. Fukuhara, T. Ishii, S. Sato, X. Wang, Y. Tanino, T. Ishida, M. Munakata (Fukushima, Japan). Clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of long-term asthma control. Eur Respir J 2009; 34: Suppl. 53, 3967

Member's Comments

No comment yet.

Related content which might interest you: Usefulness of fractional exhaled nitric oxide (FeNO) as a marker of asthma control Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Fractional exhaled nitric oxide (FeNO) for an early diagnosis of asthma Source: Eur Respir J 2006; 28: Suppl. 50, 677s Year: 2006 The clinical utility of exhaled nitric oxide (eNO) in asthma, the first 1,000 patients Source: Eur Respir J 2004; 24: Suppl. 48, 304s Year: 2004 Clinical utility of fractional exhaled nitric oxide in severe asthma management Source: Eur Respir J, 55 (3) 1901633; 10.1183/13993003.01633-2019 Year: 2020 Is exhaled nitric oxide (eNO) an indipendent outcome measure in chronic stable asthma? Source: Eur Respir J 2002; 20: Suppl. 38, 196s Year: 2002 Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD Source: Breathe, 15 (4) 306; 10.1183/20734735.0268-2019 Year: 2019 Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients Source: Eur Respir J 2008; 31: 539-546 Year: 2008 Accuracy of exhaled nitric oxide to predict a loss of asthma control in well-controlled patients Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 Diagnosing asthma using exhaled nitric oxide (eNO) measurements Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma Year: 2003 Fractional exhaled nitric oxide (FeNO) could be a good predictor for the effectiveness of inhaled corticosteroid (ICS) in patients with COPD Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009 Levels of asthma control and exhaled nitric oxide Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Usefulness of fractional exhaled nitric oxide (FeNO) for early diagnosis of asthma in patients with nonspecific respiratory symptoms Source: Annual Congress 2009 - From cough to sound analysis of breathing Year: 2009 Exhaled nitric oxide (FeNO) in relation to exacerbation of childhood asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children Source: Eur Respir J 2003; 21: 433-438 Year: 2003 The oropharyngeal contribution to exhaled nitric oxide (eNO) levels Source: Eur Respir J 2001; 18: Suppl. 33, 460s Year: 2001 The assessment of exhaled nitric oxide fraction in monitoring asthma control: How to raise the clinical relevance? Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010 Exhaled nitric oxide in the assessment of asthma control Source: Eur Respir J 2007; 30: Suppl. 51, 18s Year: 2007